Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Cholangiocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Pancreatitis 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroblastoma 1Multiple Myeloma 1Locally Advanced Cervical Adenocarcinoma 1Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1Ganglioneuroblastoma 1Choledocholithiasis 1Cholangitis 1Cervical Adenocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Dexamethasone 87daratumumab 49Lenalidomide 49pomalidomide 33Bortezomib 32Cyclophosphamide 31carfilzomib 25Calcium Dobesilate 21talquetamab 19fludarabine 18isatuximab 16iberdomide 16Magnetic Resonance Spectroscopy 16Specimen Handling 15Biopsy 14selinexor 12Melphalan 11belantamab mafodotin 10dexamethasone acetate 9dexamethasone 21-phosphate 8elotuzumab 7auricularum 7venetoclax 6tocilizumab 5fludarabine phosphate 5X-Rays 5Blood Specimen Collection 5ruxolitinib 4Methylprednisolone 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Multiple Myeloma × Congresses as Topic × Clear all
NCT06572605 2025-09-19

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

City of Hope Medical Center

Phase 1/2 Recruiting
20 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡